PsychiatryNews.net

Psychiatry Xagena

Search results for "Antipsychotic drugs"

The U.S. FDA ( Food and Drug Administration ) approved Aripiprazole ( Abilify ) for maintaining efficacy in patients with bipolar I disorder with a recent manic or mixed episode who had been stabilize ...


The FDA ( Food and Drug Administration ) issued a public health advisory to alert health care providers, patients, and patient caregivers to new safety information concerning an unapproved ( i.e., “o ...


In two double-blind, randomized, multicenter studies evaluated the investigational use of intramuscular ( IM ) Aripiprazole ( Abilify ) in patients with either acute bipolar mania or schizophrenia. ...


A head-to- head study comparing Olanzapine and Fluoxetine capsules ( OFC ) and Lamotrigine for the treatment of bipolar depression, showed that patients treated with OFC experienced significantly gre ...


A study in youth who are missing part of a chromosome is further implicating a suspect gene in schizophrenia. Youth with this genetic chromosomal deletion syndrome already had a nearly 30-fold highe ...


Second-generation antipsychotic drugs are not necessarily better than the first-generation drug Haloperidol ( Haldol ) at treating a first episode of schizophrenia.Second-generation drugs, introduced ...


Second-generation antipsychotic drugs are not necessarily better than the first-generation drug Haloperidol ( Haldol ) at treating a first episode of schizophrenia.Second-generation drugs, introduced ...


Saphris ( Asenapine ) is a psychotropic agent indicated for acute treatment of schizophrenia in adults and acute treatment of manic or mixed episodes associated with bipolar I disorder with or without ...


Bipolar disorder appears to increase the risk of early death from medical illnesses, according to a literature review study published in the journal Psychiatric Services.The researchers comprehensivel ...


Taking newer types of antipsychotic drugs could increase a person’s risk of developing dangerous blood clots, according to a new University of Nottingham study published on British Medical Journal.Ven ...